Athens, April 13, 2021 — During these turbulent times with the COVID-19 pandemic, everyone should prioritize their mental health and seek ways to support it. Under these circumstances, the Department of Psychiatry of the University of Athens has joined forces with the Feel program to develop a guide that will be useful to everyone who needs to manage their excessive worry and insecurity about the future. The guide includes practical tips and advice for a healthy state of mind and can be accessed at the official website of the Department of Psychiatry of the University of Athens for free. The next step towards helping everyone during lockdown will be a series of free webinars on diverse topics hosted by licensed therapists.
Dr. Lambis Papageorgiou, Professor and Director of the Department of Psychiatry of the University of Athens, stated “Technology has made it easier than ever for people to receive mental health support from the safety of their homes. Our clinic has been a pioneer and great supporter of such initiatives and we have worked with various technology teams over the years. Feel was one of the programs that we have successfully collaborated with for research purposes, which led us to join forces again to create mental health material for anyone who needs support. It is very important to feel that we are not alone.”
Feel is a holistic mental health program that combines artificial intelligence and science to improve a person’s emotional state, by bringing objective data for the first time and delivering on-time mental health support when they need it most. It was created by Feel Therapeutics, a startup company with collaborations with large Health & Life insurers and universities. The company, despite the financial instability and uncertainty of the future, launched a new program, Feel Relief. Feel Relief is a new telepsychiatry program designed to help everyone manage their excessive worry during the COVID-19 pandemic, and is available in the USA and Greece.
George Eleftheriou, CEO & Co-Founder of Feel Therapeutics, said, “We envision a world where technology and infrastructure will allow us to provide personalized mental health care and support 24/7. With the right use of technology, we will be able to fill many gaps in the field of mental health, especially at crucial times like this. Being a startup ourselves, we find it very important to find room for development and provide solutions and programs that respond to the needs of society, so that no one will ever suffer alone”.
Feel Therapeutics, Inc. is developing Digital Biomarkers and Therapeutics to bring objective data and measurement in the way we diagnose, manage, and care for Mental Health. The company is backed by top-tier investors (Felicis, Anthemis, SOSV) and has partnerships with large pharmaceutical companies to develop novel digital biomarkers and bring digital health solutions to market as standalone programs or alongside medications. Feel Therapeutics is headquartered in San Francisco, with additional offices in Europe. For more information, visit http://www.feeltherapeutics.com or contact us at email@example.com.